Media & Announcements
Polpharma Group at CPHI Milan 2026: Strengthening Partnerships Across the Global Pharmaceutical Value Chain
At CPHI Milan 2026, a Polpharma delegation led by CEO Sebastian Szymanek met partners on APIs, finished dosage forms, CDMO services and new technologies.
Group News
October 21, 2026
Polpharma at EFNI 2026: Building Innovation, Resilience and Europe’s Future
At EFNI 2026 in Sopot, Polpharma shared its innovation experience and joined debates on resilient supply chains and Europe’s industrial future.
Group News
October 21, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Science & Innovation
ZF Polpharma
July 1, 2021
Polpharma invests PLN 300 million in R&D
An EIB innovation loan supports Polpharma's PLN 300 million R&D investment, expanding access to modern therapies for patients in Poland and Europe.
Group News
ZF Polpharma
June 25, 2021
PLN 800 million for R&D and green investment
Polpharma secures a PLN 800 million loan from Polish and international banks to fund R&D, new APIs, renewable energy and lower CO2 emissions.
Corporate Social Responsibility
ZF Polpharma
June 24, 2021
Polpharma as the leader in the pharmaceutical sector in the 15th Ranking of Responsible Companies in Poland
Polpharma tops the pharmaceutical sector in the 15th Ranking of Responsible Companies, which assessed nearly 80 firms on CSR management quality.
Science & Innovation
Polpharma Group
Polpharma Scientific Foundation
June 24, 2021
20th anniversary gala of the Polpharma Scientific Foundation
The Polpharma Scientific Foundation celebrates its 20th anniversary, having awarded nearly PLN 27 million in 78 grants, scholarships and thesis prizes.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY